Showing results (131-140 of 8,931) with videos related to
Sort By:
Pageof 894
Journal of Cancer Research and Clinical Oncology|April 2, 2016
DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urotheliumHans Helmut Dahm, Claudia von der Haar, Herbert RübbenJournal of Cancer Research and Clinical Oncology|May 15, 2016
Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancerSeon Ae Roh, In Ja Park, Yong Sik Yoon, et al.Journal of Cancer Research and Clinical Oncology|June 4, 2016
Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancerNaoki Takahashi, Satoru Iwasa, Yusuke Sasaki, et al.Journal of Cancer Research and Clinical Oncology|July 26, 2017
Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cellsKati Erdmann, Knut Kaulke, Christiane Rieger, et al.Journal of Cancer Research and Clinical Oncology|August 14, 2017
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patientsYueh-Hsiang Liao, Chia-Ing Li, Cheng-Chieh Lin, et al.Journal of Cancer Research and Clinical Oncology|September 22, 2017
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignanciesC Boglione-Kerrien, S Picard, C Tron, et al.Journal of Cancer Research and Clinical Oncology|September 22, 2017
Lung cancer screening with MRI: results of the first screening roundMichael Meier-Schroers, Rami Homsi, Dirk Skowasch, et al.Journal of Cancer Research and Clinical Oncology|September 16, 2017
Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignanciesNils Winkelmann, Vivien Schäfer, Jenny Rinke, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1988
Preneoplastic rat liver cells in vitro: slow progression without promoters, hormones, or growth factorsR Kerler, H M RabesJournal of Cancer Research and Clinical Oncology|January 1, 1988
Dietary effects on initiation and promotion of hepatocarcinogenesis in ratS Hendrich, H P Glauert, H C PitotPageof 894